| Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 4036 | 2018 |
| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1814 | 2020 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 175 (4), 998-1013. e20, 2018 | 1481 | 2018 |
| The human tumor microbiome is composed of tumor type–specific intracellular bacteria D Nejman, I Livyatan, G Fuks, N Gavert, Y Zwang, LT Geller, ... Science 368 (6494), 973-980, 2020 | 1465 | 2020 |
| Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 1389 | 2017 |
| The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy V Gopalakrishnan, BA Helmink, CN Spencer, A Reuben, JA Wargo Cancer cell 33 (4), 570-580, 2018 | 1182 | 2018 |
| Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016 | 958 | 2016 |
| The microbiome, cancer, and cancer therapy BA Helmink, MAW Khan, A Hermann, V Gopalakrishnan, JA Wargo Nature medicine 25 (3), 377-388, 2019 | 942 | 2019 |
| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance W Roh, PL Chen, A Reuben, CN Spencer, PA Prieto, JP Miller, ... Science translational medicine 9 (379), eaah3560, 2017 | 773 | 2017 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 735 | 2018 |
| Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Y Wang, DH Wiesnoski, BA Helmink, V Gopalakrishnan, K Choi, ... Nature medicine 24 (12), 1804-1808, 2018 | 605 | 2018 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 479 | 2021 |
| The gut microbiota influences anticancer immunosurveillance and general health B Routy, V Gopalakrishnan, R Daillère, L Zitvogel, JA Wargo, G Kroemer Nature Reviews Clinical Oncology 15 (6), 382-396, 2018 | 444 | 2018 |
| Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised … RN Amaria, PA Prieto, MT Tetzlaff, A Reuben, MC Andrews, MI Ross, ... The Lancet Oncology 19 (2), 181-193, 2018 | 281 | 2018 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 275 | 2021 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 176 (1), 404, 2019 | 218 | 2019 |
| Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ... Cell research 29 (10), 846-861, 2019 | 203 | 2019 |
| TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ... Cancer discovery 7 (10), 1088-1097, 2017 | 183 | 2017 |
| Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma A Reuben, CN Spencer, PA Prieto, V Gopalakrishnan, SM Reddy, ... NPJ genomic medicine 2 (1), 10, 2017 | 132 | 2017 |
| Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer SM Reddy, A Reuben, S Barua, H Jiang, S Zhang, L Wang, ... Cancer immunology research 7 (6), 1025-1035, 2019 | 89 | 2019 |
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer Ctr在 mdanderson.org 的电子邮件经过验证
